Skip to content
Ashvattha Therapeutics
Ashvattha Therapeutics
  • About Us
    • Senior Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • D6-B483
    • OP-801
    • D-4517.2
    • OP-101
  • News
  • Resources
  • Careers
  • Contact
Ashvattha Therapeutics
  • About Us
    • Senior Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • D6-B483
    • OP-801
    • D-4517.2
    • OP-101
  • News
  • Resources
  • Careers
  • Contact

Resource Type: Media

Ashvattha previews plans for long Covid trial in mid-2023

Clinical Trials Arena

Ashvattha’s OP-101 boosts clinical outcomes in Phase IIa Covid-19 trial

Clinical Trials Arena

Getting Across Tissue Barriers for Precise Delivery of Drugs with Jeff Cleland Ashvattha Therapeutics

Empowered Patient Podcast

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma’s almanac

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma’s almanac

Ashvattha’s new self-administered anti-VEGF therapy may address unmet needs for DME

Pharmaceutical Technology

Safety data for at-home subcutaneous injection option for treatment of wet AMD, DME

Ophthalmology Times

Phase 1 safety data for subcutaneous anti-VEGF candidate for wet AMD, DME presented at ARVO

Moderna Retina

Neurologists test novel compound for lung and brain injury in severe COVID-19 patients

UT Health Houston News

Recent Posts

  • Ashvattha Therapeutics Announces First Patient Enrolled in a Phase 1 Study of [18F]OP-801 for Use as Imaging Agent
  • Ashvattha Therapeutics to Present at Upcoming Investor Conferences
  • Ashvattha Therapeutics to Present at Biotech Showcase 2023
  • Ashvattha Therapeutics Announces the Appointment of Steve Maricich, M.D., Ph.D. as Chief Medical Officer
  • Ashvattha Therapeutics Announces Preclinical Data on Hydroxyl Dendrimer Based PET Tracer [18F]OP-801 Presented at the 2022 World Molecular Imaging Congress

Recent Comments

    Archives

    • February 2023
    • January 2023
    • October 2022
    • September 2022
    • August 2022
    • July 2022
    • June 2022
    • May 2022
    • April 2022
    • September 2021
    • June 2021
    • May 2021
    • April 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • August 2020
    • June 2020
    • May 2020

    Categories

    • In the News
    • Press Release

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    Howdy, this is Creativo

    We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

    Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

    Change everything from: background color, font color, font size, sidebar headings and more.

    © Copyright 2023 Ashvattha Therapeutics.
    • Privacy Policy
    © 2023 Ashvattha Therapeutics • Built with GeneratePress